Baillie Gifford - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50,225,492
-24.4%
1,637,076
-1.3%
0.05%
-17.9%
Q2 2023$66,458,619
-13.9%
1,658,563
-12.3%
0.06%
-20.0%
Q1 2023$77,165,222
+7.1%
1,890,841
+1.3%
0.07%
-6.7%
Q4 2022$72,074,870
-26.7%
1,866,741
+1.0%
0.08%
-25.7%
Q3 2022$98,285,000
-12.9%
1,847,797
-4.5%
0.10%
-12.9%
Q2 2022$112,796,000
-30.3%
1,934,752
-8.7%
0.12%
+2.7%
Q1 2022$161,767,000
+14.2%
2,119,600
-10.0%
0.11%
+44.9%
Q4 2021$141,714,000
+21.2%
2,355,240
+12.8%
0.08%
+27.9%
Q3 2021$116,917,000
-8.4%
2,087,807
-0.7%
0.06%
-1.6%
Q2 2021$127,595,000
-13.1%
2,102,759
+0.3%
0.06%
-24.4%
Q1 2021$146,872,000
+25.0%
2,095,481
+6.7%
0.08%
+26.2%
Q4 2020$117,513,000
+11.1%
1,963,795
+11.6%
0.06%
-11.0%
Q3 2020$105,750,000
+38.1%
1,758,989
+20.5%
0.07%
+25.9%
Q2 2020$76,587,000
+61.8%
1,459,626
+3.4%
0.06%
+13.7%
Q1 2020$47,341,000
-24.7%
1,411,892
+1.8%
0.05%
-16.4%
Q4 2019$62,852,000
+43.4%
1,387,445
+20.5%
0.06%
+22.0%
Q3 2019$43,845,000
+1.3%
1,151,710
+15.8%
0.05%
+8.7%
Q2 2019$43,265,000
+14.7%
994,839
+0.4%
0.05%
+12.2%
Q1 2019$37,715,000
-6.1%
990,908
+6.1%
0.04%
-21.2%
Q4 2018$40,161,000
+1.9%
933,541
+16.4%
0.05%
+20.9%
Q3 2018$39,418,000
+111.3%
802,009
+37.8%
0.04%
+115.0%
Q2 2018$18,653,000
+17.4%
582,000
+14.1%
0.02%
+5.3%
Q1 2018$15,890,000
-6.0%
510,097
+37.8%
0.02%
-9.5%
Q4 2017$16,898,000
+40.4%
370,162
+15.5%
0.02%
+40.0%
Q3 2017$12,038,000
-16.2%
320,582
+6.5%
0.02%
-21.1%
Q2 2017$14,358,000
+47.4%
301,000
+40.9%
0.02%
+35.7%
Q1 2017$9,740,000
+41.2%
213,6000.0%0.01%
+27.3%
Q4 2016$6,899,000
-5.6%
213,6000.0%0.01%0.0%
Q3 2016$7,309,000
+1.4%
213,6000.0%0.01%
-15.4%
Q2 2016$7,205,000
+394.5%
213,600
+676.7%
0.01%
+333.3%
Q1 2016$1,457,000
-27.6%
27,500
+5.0%
0.00%0.0%
Q4 2015$2,012,000
+86.8%
26,2000.0%0.00%
+50.0%
Q3 2015$1,077,00026,2000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders